A Multicenter Randomized Double-blind Placebo-controlled Parallel Arm Study to Assess the Safety and Efficacy of a Single Treatment of BOTOX Followed by an Optional Open-Label Treatment with BOTOX in Female Subjects with Interstitial Cystitis/Blad

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Interstitial Cystitis/bladder Pain Syndrome (ic/bps)
  • Age: Between 18 Year(s) - 75 Year(s)
  • Gender: Female
  • Other Inclusion Criteria:
    1. IC/BPS for at least 6 months and confirmed dominant bladder-derived pain, without Hunner lesions.

You may not be eligible for this study if the following are true:

    1. Anything other than a positive response to the inclusion criteria above will result in exclusion from study participation.



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.